Stage II Invasive Lobular Carcinoma: Tara's Survivor Story

Patient Info: Tara, Female, 50s | Stage II

Biomarkers: Estrogen-based breast cancer

As of April 2023, Tara was in survivorship after bilateral mastectomy with tissue expanders for Stage II ILC, with clear margins, clear lymph nodes, right-breast LCIS, and no chemotherapy because of cardiac risk.

Lobular Breast Cancer AllianceRead more →

Breast Cancer: Debbie's Survivor Story

Patient Info: Debbie Bliss, Female

As of March 2023, Debbie Bliss was living in survivorship after thymus cancer and breast cancer, had accepted her post-mastectomy body, and remained active in her knitwear-design career.

Breast cancer that spread to the thymus gland

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Oestrogen receptor-positive; progesterone receptor-positive; HER2-negative

Metastatic Site: thymus

She had a good response after 4 cycles of abemaciclib, anastrozole and goserelin and continued endocrine treatment with surveillance of the opposite breast.

PubMed CentralRead more →

Stage IIB Breast Cancer Treatment Followed by BRCA1 Testing

Patient Info: Anonymized, Female | Stage II

Biomarkers: BRCA1 pathogenic variant

She completed 10 years of endocrine therapy without evidence of breast-cancer recurrence.

PubMed CentralRead more →

Triple-Negative Bilateral Breast Cancer Treated With Surgery, Radiation, and Oral Chemotherapy

Patient Info: Anonymized, Female | Stage I

Biomarkers: Triple-negative breast cancer; germline BRCA1 pathogenic variant confirmed later

She completed radiotherapy and 2 years of tegafur-uracil without evidence of breast-cancer recurrence.

PubMed CentralRead more →

HER2-positive breast cancer on hemodialysis: partial response to T-DM1 then no metabolically active disease

Patient Info: Anonymized, Female, 60s | Stage II

Biomarkers: Hormone receptor-positive; HER2/neu-positive; E-cadherin-positive; Ki-67 55-60%; luminal B type

As of March 2023, after 12 total cycles of T-DM1 and modified radical mastectomy, PET-CT showed no metabolically active disease, and she continued endocrine therapy and dialysis.

PubMed CentralRead more →

Rare breast blood-vessel cancer (angiosarcoma) in a teenage girl

Patient Info: Anonymized, Female

Biomarkers: Testing for Li-Fraumeni syndrome and POT1 mutation was inconclusive; no inherited cancer predisposition was established

She remained in remission 3 years after diagnosis and continued annual MRI surveillance of the reconstructed and opposite breasts.

PubMed CentralRead more →

BRCA2 Breast Cancer: Sue's Survivor Story

Patient Info: Sue Friedman, Female, Under 40

Biomarkers: BRCA2 mutation

As of February 2023, Sue Friedman was a long-term breast cancer survivor and founder of FORCE after a BRCA2-associated breast cancer and recurrence; the video is educational and does not state current active disease, NED, or metastatic status for Sue.

The Patient StoryRead more →

Stage II Breast Cancer: Renée's Patient Story

Patient Info: Renée, Female, Under 40 | Stage II

Biomarkers: Not genetically inherited; breast cancer linked by her team to prior doxorubicin exposure and total-body radiation

As of February 2023, Renée described stable health, working treatments, good bloodwork, and ongoing long-term hormone/anti-cancer therapy; she did not consider herself cancer-free and preferred survivor/thriver language.

The Patient StoryRead more →

Rare breast cancer subtype that recurred years later in a more aggressive form

Patient Info: Anonymized, Female | Stage IV

Biomarkers: CD117 focally positive in the transformed component; high Ki-67; hormone-receptor status was unknown at the original diagnosis

Metastatic Site: lungs

One year after treatment for the late chest-wall recurrence, CT showed another local recurrence and metastatic nodules in both lungs. She chose to continue treatment elsewhere.

PubMed CentralRead more →

Stage IV BRCA Invasive Ductal Carcinoma: Langley's Patient Story

Patient Info: Langley Perer, female, Under 40 | Stage IV

Biomarkers: inherited BRCA mutation

Metastatic Site: brain, bones, leptomeninges

After 1 year on a PARP inhibitor, Langley’s metastatic breast cancer remained in check without progression and some lesions had begun to shrink.

Dana-FarberRead more →

Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy E., Female, Under 40

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had been told she was all-clear/cancer-free after chemotherapy, had undergone double mastectomy with staged reconstruction planning, and was continuing close oncology reviews every 3-4 months.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Lucy's Patient Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had gone through fertility preservation, chemotherapy, and double mastectomy for Stage II grade 3 triple-negative breast cancer with BRCA1 mutation; no NED or recurrence status was stated.

The Patient StoryRead more →

Stage II HER2-Positive Invasive Ductal Carcinoma: Lanie's Patient Story

Patient Info: Lanie Jones, Female, Under 40 | Stage II

Biomarkers: HER2-positive; Li-Fraumeni syndrome / TP53 mutation; BRCA-negative

As of January 2023, Lanie was living with Li-Fraumeni syndrome after 5 cancer diagnoses and was on lifelong maintenance chemotherapy while advocating for genetic testing and specialized surveillance.

The Patient StoryRead more →

Stage I Breast Cancer: Catriona's Survivor Story

Patient Info: Catriona, Female, 60s | Stage I

Catriona described herself as a breast cancer survivor who had recovered after treatment and was focused on long-term wellbeing and family.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Sarah's Patient Story

Patient Info: Sarah | Stage II

Sarah remains in active treatment, with the plan changed to focus on chemotherapy, and she is hopeful about completing treatment and returning to daily life.

Our Cancer StoriesRead more →

Breast Cancer: Teri's Survivor Story

Patient Info: Teri

Her cancer is in remission, and she continues hormone therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Alicia's Patient Story

Patient Info: Alicia, Female, 50s | Stage II

As of 2023, Alicia had undergone Stage II breast cancer treatment with mastectomy, hormone therapy, and DIEP flap reconstruction, with no treatment side effects described and a focus on recovery and wellbeing.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Lauren's Patient Story

Patient Info: Lauren | Stage I

Lauren remained in active care with radiation therapy and hormone therapy ongoing.

Our Cancer StoriesRead more →

HR-Positive Invasive Ductal Carcinoma: Annette's Patient Story

Patient Info: Annette La Fontaine, Female

Biomarkers: ER-positive; PR-positive; HER2-negative

As of January 2023, Annette was in survivorship after bilateral mastectomy and reconstruction and was taking a daily aromatase inhibitor to reduce recurrence risk while rebuilding body confidence and emotional well-being.

The Patient StoryRead more →

Stage II Breast Cancer: Angelina's Patient Story

Patient Info: Angelina, Female, 50s | Stage II

As of 2023, Angelina was undergoing Stage II breast cancer treatment with DIEP mastectomy, chemotherapy, radiation therapy, and hormone therapy, and was focused on recuperation and future goals.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Jamie's Patient Story

Patient Info: Jamie, Female, 40s | Stage II

Jamie was newly diagnosed with Stage II breast cancer in 2023 and had not yet started treatment; her plan included mastectomy, chemotherapy, radiation therapy, and targeted therapy.

Our Cancer StoriesRead more →

Stage II HR-Positive Breast Cancer: Becki's Patient Story

Patient Info: Becki, Female, 40s | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of 2023, Becki was receiving ongoing treatment for Stage II triple-positive breast cancer after recently completing mastectomy and experiencing chemotherapy-related fatigue, hair loss, and chemo fog.

Our Cancer StoriesRead more →

Stage 0 Breast Cancer: Jane's Patient Story

Patient Info: Jane | Stage 0

Jane was still receiving treatment after choosing lymphadenectomy for stage 0 breast cancer diagnosed in July 2023.

Our Cancer StoriesRead more →